METHODS TO PREDICT PATIENT RESPONSIVENESS TO TYROSINE KINASE INHIBITORS
摘要
<p>This invention relates to the use of two form of genomic analysis to predict responsiveness of patients with tyrosine kinase responsive such as Philadelphia chromosome positive leukemia to treatment with tyrosine kinase inhibitor drugs.</p>
